Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0268596 (
EMA
)
2,520
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Punctin/
MADD
-4, a member of the ADAMTSL extracellular matrix protein family, was identified as an anterograde synaptic organizer in the nematode
Caenorhabditis elegans.
At GABAergic neuromuscular junctions, the short isoform
MADD
-4B binds the ectodomain of neuroligin NLG-1, itself a postsynaptic organizer of inhibitory synapses. To identify the molecular bases of their partnership, we generated recombinant forms of the two proteins and carried out a comprehensive biochemical and biophysical study of their interaction, complemented by an
in vivo
localization study. We show that spontaneous proteolysis of
MADD
-4B first generates a shorter N-
MADD
-4B form, which comprises four
thrombospondin
(
TSP
) domains and one Ig-like domain and binds NLG-1. A second processing event eliminates the C-terminal Ig-like domain along with the ability of N-
MADD
-4B to bind NLG-1. These data identify the Ig-like domain as the primary determinant for N-
MADD
-4B interaction with NLG-1
in vitro
We further demonstrate
in vivo
that this Ig-like domain is essential, albeit not sufficient
per se
, for efficient recruitment of GABA
A
receptors at GABAergic synapses in
C. elegans
The interaction of N-
MADD
-4B with NLG-1 is also disrupted by heparin, used as a surrogate for the extracellular matrix component, heparan sulfate. High-affinity binding of heparin/heparan sulfate to the Ig-like domain may proceed from surface charge complementarity, as suggested by homology three-dimensional modeling. These data point to N-
MADD
-4B processing and cell-surface proteoglycan binding as two possible mechanisms to regulate the interaction between
MADD
-4B and NLG-1 at GABAergic synapses.
...
PMID:The Ig-like domain of Punctin/MADD-4 is the primary determinant for interaction with the ectodomain of neuroligin NLG-1. 3292 59